Rhonda Patrick

What do you think about some of that data on heart issues or bone loss?

Does that concern you at all?

Or the neuropsychiatric, that's another one on the eyes.

What I'm interested in is we have these GLP-1 receptors like on so many different tissues.

Systemically, like how is it beneficial?

Is it not beneficial?

I don't know that we really know.

We have data where there's obviously positive effects.

You see like reduced Alzheimer's disease incidents with people taking these GLP-1 receptor agonists.

But how much of that is due to like weight loss?

they're looking more metabolically healthy.

That's fascinating.

Or like you said, if you're doing this microdose, maybe you're not going to be as satiated.

Like you'll still have somewhat of an appetite because you're on such a low dose.

Maybe you're going to have a little bit of an effect.

Yeah.

This just reminded me of something that we should have pointed out.

Talking about the protein requirements, grams per kilogram body weight, I do think it's important, like we were just talking about obese people.

Yeah, exactly.

Where it's like, most people aren't going to do a DEXA scan to see what their lean body mass is.